These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 34256103)

  • 1. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
    Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
    Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Characterization of Folic Acid Conjugated Gemcitabine Tethered Silver Nanoparticles (FA-GEM-AgNPs) for Targeted Delivery.
    Karuppaiah A; Rajan R; Hariharan S; Balasubramaniam DK; Gregory M; Sankar V
    Curr Pharm Des; 2020; 26(26):3141-3146. PubMed ID: 32175835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
    Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
    Wang F; Wang Y; Ma Q; Cao Y; Yu B
    Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialic Acid Conjugated Chitosan Nanoparticles: Modulation to Target Tumour Cells and Therapeutic Opportunities.
    Rana R; Rani S; Kumar V; Nakhate KT; Ajazuddin ; Gupta U
    AAPS PharmSciTech; 2021 Dec; 23(1):10. PubMed ID: 34862568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
    Nasri N; Saharkhiz S; Dini G; Yousefnia S
    Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.
    El-Sheikh SMA; Khairy MH; Osama E; Metwally MMM; Galal AAA
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):631-643. PubMed ID: 33104848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles.
    Nemati M; Bani F; Sepasi T; Zamiri RE; Rasmi Y; Kahroba H; Rahbarghazi R; Sadeghi MR; Wang Y; Zarebkohan A; Gao H
    Mol Pharm; 2021 Dec; 18(12):4341-4353. PubMed ID: 34779630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

  • 10. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-responsive chitosan/acrylamide/gold/nanocomposite supported with silver nanoparticles for controlled release of anticancer drug.
    Nasef SM; Khozemy EE; Mahmoud GA
    Sci Rep; 2023 May; 13(1):7818. PubMed ID: 37188828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Nanocomposites of Different Antibiotics Coupled with Green Synthesized Chitosan-Based Silver Nanoparticles: Characterization, Antibacterial, in vivo Toxicological and Biodistribution Studies.
    Asghar MA; Yousuf RI; Shoaib MH; Asghar MA; Ansar S; Zehravi M; Abdul Rehman A
    Int J Nanomedicine; 2020; 15():7841-7859. PubMed ID: 33116504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-encapsulated nickel oxide, tin dioxide, and farnesol nanoparticles: Antimicrobial and anticancer properties in breast cancer cells.
    Mickymaray S; Al Aboody MS; Eraqi MM; Alhoqail WA; Alothaim AS; Suresh K; Arulselvan P
    Int J Biol Macromol; 2023 Sep; 248():125799. PubMed ID: 37451381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.
    Arif M; Raja MA; Zeenat S; Chi Z; Liu C
    J Biomater Sci Polym Ed; 2017 Jan; 28(1):50-62. PubMed ID: 27691398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.
    Youngren-Ortiz SR; Hill DB; Hoffmann PR; Morris KR; Barrett EG; Forest MG; Chougule MB
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):299-321. PubMed ID: 28277892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of curcumin and tamoxifen loaded in pH-responsive gemini surfactant nanoparticles on breast cancer cells.
    Ashin ZF; Sadeghi-Mohammadi S; Vaezi Z; Najafi F; AdibAmini S; Sadeghizadeh M; Naderi-Manesh H
    BMC Complement Med Ther; 2024 Sep; 24(1):337. PubMed ID: 39304876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSH-responsive and folate receptor-targeted pyridine bisfolate-encapsulated chitosan nanoparticles for enhanced intracellular drug delivery in MCF-7 cells.
    Elshami FI; Elrefaei G; Ibrahim MM; Elmehasseb I; Shaban SY
    Carbohydr Res; 2024 Sep; 543():109207. PubMed ID: 39018698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells.
    Oliveira C; Neves NM; Reis RL; Martins A; Silva TH
    Nanomedicine (Lond); 2018 Aug; 13(16):2037-2050. PubMed ID: 30189774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy.
    Ma T; Jiang JL; Qi WX; Chen JY; Xu HP
    Drug Des Devel Ther; 2022; 16():2395-2406. PubMed ID: 35923931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine-Phospholipid Complex Loaded Lipid Nanoparticles for Improving Drug Loading, Stability, and Efficacy against Pancreatic Cancer.
    Dora CP; Kushwah V; Yadav V; Kuche K; Jain S
    Mol Pharm; 2024 Jun; 21(6):2699-2712. PubMed ID: 38747900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.